S

Seethalakshmi

Active Director Director DIN 09472484
DIN 09472484 First appointment Jan 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Seethalakshmi

Data last updated:

Seethalakshmi is a Director at Newrish Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Newrish Pharmaceuticals Private Limited reported revenue of ₹1.69 Cr (FY 2025).

DIN 09472484
Primary Designation Director
Industry Pharma
First Appointment 19 Jan 2022
Oldest Company Age 4 yrs
Largest company Newrish Pharmaceuticals Private Limited · ₹1.69 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20222022₹1.69 Cr (FY 2025)Active

Board colleagues of Seethalakshmi

Directorship timeline

Open interactive timeline →
Newrish Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seethalakshmi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seethalakshmi

Seethalakshmi currently holds 1 directorship: Newrish Pharmaceuticals Private Limited (Director, since 19 Jan 2022, revenue ₹1.69 Cr (FY 2025)).

Seethalakshmi was first appointed on 19 Jan 2022 as Director at Newrish Pharmaceuticals Private Limited.

The current boards of Seethalakshmi's companies include Muthukumar Amirthalingam (Newrish Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available